Abstract
The central importance of functional host professional antigen-presenting cell (APC) in the immune response against cancer has been well-defined (1). Dendritic cells (DC) are highly specialized professional APC with potent capacity to capture, process, and present antigen to T cells (2). Unfortunately, tumor cells interfere with host DC maturation and function (3). To circumvent tumor-mediated inhibition of DC maturation and function in vivo, DC that have undergone cytokine-stimulated maturation ex vivo have been effectively utilized in clinical trials and murine cancer models (4–8) Antigen-specific cytotoxic T lymphocytes (CTL) responses have been achieved utilizing ex vivo antigen-pulsed DC (5,9–11). Additionally, novel tumor antigen-delivery systems utilizing cytokine gene-transduced tumor cells and DC (4,7) or fusion of tumor cells with DC have resulted in induction of antitumor immunity (12,13). Delivery of tumor antigens by ex vivo stimulated DC has been shown to be superior to purified peptides in avoiding CTL tolerization (14). Vaccination with multiple tumor antigens may be superior to the use of a single epitope (15,16) and these responses can be further enhanced by the co-administration of immune-potentiating cytokines (4,7). We have demonstrated previously that interleukin (IL)-7-transduced tumor cells administered intratumorally in conjunction with DC elicit potent antitumor responses in a murine model of established lung cancer (7).
Keywords
- Dendritic Cell
- Intratumoral Injection
- Complete Tumor Eradication
- Transduce Tumor Cell
- Multiple Tumor Antigen
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961–965.
Steinman, R. M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271–296.
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., et al. (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med. 2, 1096–1103.
Miller, P. W., Sharma, S., Stolina, M., Chen, K., Zhu, L., Paul, R. W., and Dubinett, S. M. (1998) Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer. Cancer Gene Ther. 5, 380–389.
Nestle, F., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., et al. (1998) Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med. 4, 328–332.
Ribas, A., Butterfield, L., McBride, W., Jilani, S., Bui, L., Vollmer, C., et al. (1997) Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res. 57, 2865–2869.
Sharma, S., Miller, P., Stolina, M., Zhu, L., Huang, M., Paul, R., and Dubinett, S. (1997) Multi-component gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with Interleukin 7/Herpes Simplex Thymidine Kinase-transduced autologous tumor and ex vivo-activated dendritic cells. Gene Ther. 4, 1361–1370.
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183, 87–97.
Boczkowski, D., Nair, S. K., Snyder, D., and Gilboa, E. (1996) Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465–472.
Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T., and Falo Jr., L. D. (1996) Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283–287.
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., et al. (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med. 1, 1297–1302.
Celluzzi, C. and Falo, L. J. (1998) Cutting edge: physical interaction between dendritic cells and tumor cells result in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160, 3081–3085.
Gong, J., Chen, D., Kashiwara, M., and Kufe, D. (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nature Med. 3, 558–561.
Toes, R., van der Voort, E., Schoenberger, S., Drijfhout, J., van Bloois, L., Storm, G., et al. (1998) Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J. Immunol. 160, 4449–4456.
Fields, R. C., Shimizu, K., and Mule, J. J. (1998) Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95, 9482–9487.
Toes, R. E., Hoeben, R. C., van der Voort, E. I., Ressing, M. E., van der Eb, A. J., Melief, C. J., and Offringa, R. (1997) Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion. Proc. Natl. Acad. Sci. USA 94, 14660–14665.
Kos, F. J. and Mullbacher, A. (1993) IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro. J. Immunol. 150, 387–393.
Mehrotra, P. T., Grant, A. J., and Siegel, J. P. (1995) Synergistic effects of IL-7 and IL-12 on human T cell activation. J. Immunol. 154, 5093–5102.
Dubinett, S. M., Huang, M., Dhanani, S., Wang, J., and Beroiza, T., (1993) Down-regulation of macrophage transforming growth factor-β messenger RNA expression by interleukin-7. J. Immunol. 151, 6670–6680.
Miller, A. R., McBride, W. H., Dubinett, S. M., Dougherty, G. J., Thacker, J. D., Shau, H., et al. (1993) Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunological properties with IL-2. Blood 82, 3686–3694.
Yuhas, J., Toya, R., and Wagner, E. (1975) Specific and nonspecific stimulation of resistence to the growth and metastasis of the line 1 lung carcinoma. Cancer Res. 35, 242–244.
Malave, I., Blanca, I., and Fuji, H. (1979) Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice. J. Natl. Cancer Inst. 62, 83–88.
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophages colony-stimulated factor. J. Exp. Med. 176, 1693–1703.
Arthur, J., Butterfield, L., Roth, M., Bui, L., Kiertscher, S., Lau, R., et al. (1997) A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4, 17–25.
Sharma, S., Wang, J., Huang, M., Paul, R., Lee, P., McBride, W., et al. (1996) Interleukin-7 gene transfer in non-small cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Can. Gene Ther. 3, 302–313.
Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., and Eisenbach, L. (1994) CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369, 67–71.
McBride, W. H., Thacker, J. D., Comora, S., Economou, J., Kelley, D., Dubinett, S. M., and Dougherty, G. J. (1992) Genetic modification of a murine fibrosarcoma to produce IL-7 stimulates host cell infiltration and tumor immunity. Cancer Res. 52, 3931–3937.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Sharma, S., Yang, S.C., Batra, R.K., Dubinett, S.M. (2003). Intratumoral Therapy with Cytokine Gene-Modified Dendritic Cells in Murine Lung Cancer Models. In: Driscoll, B. (eds) Lung Cancer. Methods in Molecular Medicine™, vol 75. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-324-0:711
Download citation
DOI: https://doi.org/10.1385/1-59259-324-0:711
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-920-9
Online ISBN: 978-1-59259-324-8
eBook Packages: Springer Protocols